Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

601 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Completed

A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

NCT00471497

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +13 more
Locations
  • University of California at Los Angeles Dept. of Hematology Clinic Los Angeles, California, United States
  • Kaiser Permanente - California Southern Dept of Kaiser South 3 San Diego, California, United States
  • Kaiser Permanente - California Northern Vallejo Med Center/Med Offices Vallejo, California, United States
  • Kaiser Permanente - California Northern Kaiser Med Vallejo, California, United States
View all 213 locations
View Trial Details
Completed

Study of Nilotinib as First Line Treatment in Philadelphia Chromosome Positive(Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

NCT01274351

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations
  • Novartis Investigative Site Eskişehir, Meselik, Turkey (Türkiye)
  • Novartis Investigative Site Istanbul, TUR, Turkey (Türkiye)
  • Novartis Investigative Site Adana, Turkey (Türkiye)
  • Novartis Investigative Site Ankara, Turkey (Türkiye)
View all 13 locations
View Trial Details

Related conditions